Market Overview

UPDATE: Morgan Stanley Reiterates On HCA On Revised Outlook


In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on HCA Holdings (NYSE: HCA), and raised the price target from $65.00 to $67.00.

In the report, Morgan Stanley noted, “HCA raised its EBITDA guidance to $7B to $7.15B reflecting TX Medicaid payments and an improved reform outlook. We updated our ‘14 EBITDA estimate to $7.15B, the high end of guidance, reflecting our expectations for a 2.8% reform benefit. We remain OW and raise our PT to $67.”

HCA closed on Wednesday at $60.99.

Latest Ratings for HCA

Jul 2019UpgradesNeutralBuy
Jun 2019MaintainsBuy
May 2019MaintainsBuyBuy

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Price Target Analyst Ratings


Related Articles (HCA)

View Comments and Join the Discussion!

Latest Ratings

WUBABOCOM InternationalDowngrades
DLTROTR GlobalUpgrades
ARCCCompass PointDowngrades
GTYHCitiInitiates Coverage On7.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Weakening Euro Eases Pressure On the ECB

Thursday Flip-Flop – Rally Gets Manic/Depressive